The Indian authorities have temporarily halted all major exports of the “AstraZeneca” anti-corona virus vaccine manufactured by the Indian Serology Institute (SII) to meet orders at home as infections increase.
A source told “Reuters” that this step will affect supplies to the “Kovacs” program of the United Nations.
The Indian Institute has delayed AstraZeneca shipments to several countries in recent days, including the United Kingdom and Brazil. India has exported more than 60 million vaccine doses to 76 countries so far, most of which are AstraZeneca.
The UK only received half of the 10 million doses it requested from SII, leading to warnings that its vaccination program may have to slow down.
The UK also faces threats to impose stricter export controls from the European Union on the doses produced there.
Source: “The Guardian”